Hiro Watanabe active positions
| Companies | Position | Start | End |
|---|---|---|---|
Deepcore, Inc.
 Deepcore, Inc. Investment ManagersFinance Deepcore, Inc. (Deepcore) is a venture capital subsidiary of publicly traded company SoftBank Group Corp. (TYO:9884) founded in 2014. The firm is headquartered in Tokyo, Japan. | Private Equity Investor | 2017-05-31 | - |
| ZERO Foundation | Founder | 2021-11-30 | - |
| President | 2021-11-30 | - | |
| Hero KK | Founder | 2022-01-31 | - |
| Private Equity Investor | 2022-01-31 | - |
Career history of Hiro Watanabe
Former positions of Hiro Watanabe
| Companies | Position | Start | End |
|---|---|---|---|
| NOVOHEART HOLDINGS INC. | Chief Operating Officer | - | - |
Statistics
International
| Japan | 4 |
| Canada | 2 |
Operational
| Private Equity Investor | 2 |
| Founder | 2 |
| President | 1 |
Sectoral
| Finance | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Deepcore, Inc.
Deepcore, Inc. Investment ManagersFinance Deepcore, Inc. (Deepcore) is a venture capital subsidiary of publicly traded company SoftBank Group Corp. (TYO:9884) founded in 2014. The firm is headquartered in Tokyo, Japan. | Finance |
| ZERO Foundation | |
| Hero KK | Finance |
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Hiro Watanabe
- Experience
